Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Matthew Delahaye"'
Publikováno v:
Disease Models & Mechanisms, Vol 16, Iss 5 (2023)
Externí odkaz:
https://doaj.org/article/8d9708597f2d4c6a9de9eee8cb27059a
Publikováno v:
Journal of Molecular and Cellular Cardiology. 173:54-56
Publikováno v:
Disease Models & Mechanisms. 16
There is an unmet need for treatments that prevent the progressive cardiac dysfunction following myocardial infarction. Mesenchymal stem/stromal cells (MSCs) are under investigation for cardiac repair; however, culture expansion prior to transplantat
Autor:
Anna M. Randi, James Tomlinson, Neil Dufton, Graeme M. Birdsey, Matthew Delahaye, Olga Boruc, Laura Dowsett, Anna Slaviero, Zhen Wang, Eliza Kalk, James Leiper, Lucy Colman, Sophie Piper
Publikováno v:
Circulation. 131:2217-2225
Background— Asymmetrical dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthesis and a risk factor for cardiovascular disease. Dimethylarginine dimethylaminohydrolase (DDAH) enzymes are responsible for ADMA breakdown. It has be
Autor:
John Wharton, Laura Dowsett, Matthew Delahaye, Beata Wojciak-Stothard, Martin R. Wilkins, Ninian N. Lang, Hilda Tsang, James Leiper, Ka Hou Lao, Lucio Iannone, Gareth Barnes, Luke Howard
Publikováno v:
Pulmonary Circulation. 3:675-691
Circulating levels of asymmetric dimethylarginine (ADMA), a nitric oxide synthase inhibitor, are increased in patients with idiopathic pulmonary hypertension (IPAH). We hypothesized that ADMA abrogates gap junctional communication, required for the c
Autor:
Zhen Wang, Simon Lambden, Olga Boruc, James Tomlinson, Ben Lee, Manasi Nandi, Peter Kelly, Matthew Delahaye, Sanjay Khadayate, Blerina Ahmetaj, Ben Caplin, James Leiper, Laura Dowsett, Anna Slaviero, Belen Torondel
Publikováno v:
Nitric Oxide. 42:130